Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | BAD | Q92934 | 1/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | DHFR | P00374 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 1/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27988934 | 0.91 | BCL2L1 (0.48) | BCL2L1BADNOTUMMCL1HSD17B10 | |
| SCHEMBL21938180 | 0.87 | BCL2L1 (0.54) | BCL2L1BADNOTUMHSD17B10GPR35 | |
| SCHEMBL6802081 | 0.85 | MCL1 (0.53) | NOTUMMCL1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL12149327 | 0.85 | BCL2L1 (0.52) | BCL2L1BADNOTUMHSD17B10GPR35 | |
| SCHEMBL6500060 | 0.83 | ALDH1A1 (0.51) | MCL1ALDH1A1DHFRACMSD | |
| SCHEMBL6497146 | 0.82 | NPC1 (0.53) | NOTUMMCL1HSD17B10KDM4EALDH1A1 | |
| SCHEMBL24183987 | 0.81 | MCL1 (0.61) | MCL1HSD17B10KDM4EALDH1A1MEN1 | |
| SCHEMBL6799953 | 0.81 | RXRA (0.55) | HSD17B10KDM4EALDH1A1USP2HPGD | |
| SCHEMBL6492370 | 0.81 | HSD17B10 (0.51) | BCL2L1BADNOTUMMCL1HSD17B10 | |
| SCHEMBL6500578 | 0.81 | HDAC7 (0.51) | BCL2L1BADNOTUMMCL1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050038035-A1 | Heterocyclic amide compounds as apolipoprotein b inhibitors | DAISO CO., LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038035-A1 | Heterocyclic amide compounds as apolipoprotein b inhibitors | APOB, APOL1, CTRB2 | BCL2L1 1236/4885BAD 1491/4885NOTUM 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.